Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  BGI Genomic's $250 Million Shenzhen IPO Scheduled for July
  Chi-Med Starts China Phase I/II Trial of Novel FGFR Inhibitor
  San Francisco's Sinovas Starts $75 Million China VC Fund
  Baheal to Market IBM's Watson Big Data Health Program to China Hospitals
  Shanghai ChemPartner Plans Reverse Merger with China's Quantum
  GSK Forms Respiratory Disease Big Data Project with Guangzhou Institute
  After US Request, China Bans Four Synthetic Opioids
  Lee's Pharm In-Licenses Asia Rights to RDS Treatment in $40 Million Deal
  Hangzhou's Venus Medtech Acquires InterValve of the US
  Sihuan Pharma Forms China Aesthetic JV with Austria's Croma-Pharma
 
Login